6095 — MedPeer Income Statement
0.000.00%
Last trade - 00:00
- ¥15bn
- ¥14bn
- ¥15bn
- 83
- 43
- 16
- 43
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,046 | 5,311 | 7,435 | 8,452 | 14,541 |
Cost of Revenue | |||||
Gross Profit | 2,117 | 3,506 | 4,855 | 5,034 | 6,867 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,485 | 4,206 | 5,652 | 7,388 | 13,538 |
Operating Profit | 561 | 1,105 | 1,784 | 1,064 | 1,002 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 557 | 1,131 | 1,812 | 1,114 | 1,047 |
Provision for Income Taxes | |||||
Net Income After Taxes | 428 | 803 | 1,332 | 815 | 638 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 395 | 726 | 1,293 | 812 | 618 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 395 | 726 | 1,293 | 812 | 618 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 21.4 | 34.5 | 57.9 | 37.9 | 45.3 |
Dividends per Share |